Unlock instant, AI-driven research and patent intelligence for your innovation.

Urine protein markers for the diagnosis of Parkinson's disease

A Parkinson's disease, urine technology, applied in the field of clinical diagnosis, can solve problems such as difficult to obtain

Active Publication Date: 2021-10-22
BEIJING NORMAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since there is no barrier between CSF and the brain, CSF is considered ideal for discovering biomarkers of neurodegenerative diseases, but due to the blood-brain barrier, CSF is more stable and more difficult to obtain than blood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Urine protein markers for the diagnosis of Parkinson's disease
  • Urine protein markers for the diagnosis of Parkinson's disease
  • Urine protein markers for the diagnosis of Parkinson's disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1 Rotarod Behavioral Detection of α-Syn(A53T) Positive Transgenic Mice

[0019] 4-week-old clean-grade male α-Syn(A53T)-positive transgenic mice [C57BL / 6J-Tg(PDGF-α-synuclein A53T) ILAS] (n=4) were purchased from the Institute of Medical Experimental Animals, Chinese Academy of Medical Sciences, The animal license is SCXK (Beijing) 2014-0011. Animal experiments followed review and approval (Animal Welfare Assurance Number: ACUC-A02-2014-007). All animals were kept in a standard environment with a 12-hour light-dark cycle (room temperature 22±1° C., humidity 65%-70%).

[0020] The rotarod behavior test was used to evaluate the motor coordination ability of the mice limbs. The rotational speed of the rotarod instrument (developed by the Institute of Materia Medica, Chinese Academy of Medical Sciences) was set to a constant speed of 25rpm, 30rpm, and 35rpm, respectively, with an interval of 30min and a time limit of 2min. The time when the mouse first fell off t...

Embodiment 2

[0026] Example 2 Immunohistochemical staining of α-Syn (A53T) positive transgenic mice

[0027] Immunohistochemical staining was performed after the last behavioral examination. Male C57BL / 6 mice of the same age were used as controls (n=3).

[0028] After the mice were anesthetized, the mice were perfused with normal saline and 4% paraformaldehyde successively, and the isolated brain was fixed in 4% paraformaldehyde for 24h, and then transferred to 4% paraformaldehyde containing 30% sucrose Dehydrate in the solid until the brain tissue sinks to the bottom. The brain tissue was removed, dehydrated, embedded and sectioned with a thickness of 4 μm. After dewaxing to water, the slices were repaired by microwave in EDTA buffer, washed with PBS buffer and then placed in 3% hydrogen peroxide solution, incubated at room temperature for 10 min, washed with PBS buffer, blocked with 5% BSA for 20 min, and then mixed with TH (1:100) antibody was incubated overnight at 4°C, and the seco...

Embodiment 3

[0030] Embodiment 3 urine collection and sample preparation

[0031] Urine samples of A53T mice were collected at the 2nd, 4th, 6th, 8th, and 10th month respectively, and the urine samples collected at the 2nd month were used as the control group. Mice were individually placed in metabolic cages overnight (12h) to collect urine samples. During the urine collection, no food was provided and water was freely available to avoid urine contamination.

[0032] The collected urine was centrifuged at 4°C and 3000×g for 10 min to remove cells and pellets, and the supernatant was stored at -80°C. Before urine protein extraction, the urine samples were centrifuged at 12000×g for 10 min at 4°C to remove cell debris. The supernatant was precipitated at 4° C. for 12 h using four volumes of pre-cooled ethanol. The above samples were centrifuged at 4°C and 12000×g for 10 min. The pellet was resuspended in lysate (8 mol / L urea, 2 mol / L thiourea, 25 mmol / L DTT and 50 mmol / L Tris). Protein ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The present invention relates to urine protein markers for diagnosing Parkinson's disease. Specifically, the present invention relates to the use of a reagent for detecting the protein content in the subject's urine in the preparation of a medicament for diagnosing the subject's Parkinson's disease, wherein the reagent for detecting the protein content in the subject's urine is a mass spectrometric identification reagent, an antibody or an antigen-binding fragment thereof.

Description

technical field [0001] The present invention relates to the technical field of clinical diagnosis. In particular, the present invention relates to urine protein markers for the diagnosis of Parkinson's disease. Specifically, the present invention relates to a urine protein marker related to human Parkinson's disease obtained by mass spectrometry proteomics technology and its application. Background technique [0002] Parkinson's disease is a neurodegenerative disease characterized by progressive motor and non-motor disturbances, see Deng, H. and L. Yuan, Genetic variants and animal models in SNCA and Parkinsondisease.Ageing Research Reviews, 2014.15: p.161- 176. Its main pathological feature is the progressive loss of dopaminergic neurons in the substantia nigra compacta of the midbrain, and the appearance of eosinophilic inclusion bodies with α-synuclein as the main component in the remaining dopaminergic neurons, namely Lewy bodies. Parkinson's disease seriously affect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N33/577G01N33/573
CPCG01N33/573G01N33/577G01N33/6893G01N2333/47G01N2333/4712G01N2333/4716G01N2333/90212G01N2333/91188G01N2333/948G01N2333/99G01N2800/2835G01N2800/52
Inventor 高友鹤李璐隽
Owner BEIJING NORMAL UNIVERSITY
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More